section name header

Pronunciation ⬇

dox-i-SYE-kleen

Classifications ⬆ ⬇

Therapeutic Classification: anti-infectives

Pharmacologic Classification: tetracyclines

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Inhibits bacterial protein synthesis at the level of the 30S bacterial ribosome.
  • Low-dose products used in the management of periodontitis inhibit collagenase.
Therapeutic effects:
  • Bacteriostatic action against susceptible bacteria.

Spectrum:

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed from the GI tract.

Distribution: Widely distributed, some CSF and good bone penetration.

Metabolism/Excretion: 20–40% excreted unchanged in urine; some inactivation in intestine and some enterohepatic circulation with excretion in bile and feces.

Half-Life: 14–17 hr (↑ in severe renal impairment).

Time/Action Profile ⬆ ⬇

( plasma concentrations)

ROUTEONSETPEAKDURATION
PO1–2 hr1.5–4 hr12 hr
IVrapidend of infusion12 hr

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Drug-drug:

Drug-Food:

Route/Dosage ⬆ ⬇

More Common Infections

Inhalational Anthrax (Postexposure)

Cutaneous Anthrax

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

IV Administration:

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Acticlate, , Doryx, Doryx MPC, Doxy, Oracea, Targadox, Vibramycin

Canadian Brand Names ⬆ ⬇

Apprilon, Doxycin, Doxytab, Periostat

Pill Image

doxycycline_hyclate _195-8724.jpg

Code ⬆

NDC Code